Silence Therapeutics (SLN) Earnings Date & Reports

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SLN is expected to report earnings to rise 43.44% to -12 cents per share on November 17

Silence Therapeutics SLN Stock Earnings Reports

Q3'26

Est.

$-0.13

Q2'26

Beat

by $0.05

Q1'26

Beat

by $0.03

Q4'25

Beat

by $0.11

Q3'25

Beat

by $0.04

The last earnings report on August 10 showed earnings per share of -9 cents, beating the estimate of -14 cents. With 425.36K shares outstanding, the current market capitalization sits at 848.81M.

View a ticker or compare two or three

SLN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days